NovaMin Technology has a total of 46 patents globally, out of which 19 have been granted. Of these 46 patents, more than 15% patents are active. United States Of America is where NovaMin Technology has filed the maximum number of patents, followed by Australia and Hong Kong. Parallelly, USA seems to be the main focused R&D center and is also the origin country of NovaMin Technology.
NovaMin Technology was founded in 2004 by Randy Scott. Company is doing business in manufacturing of dental and oral health care products. NovaMin is a bioactive substance with a tooth re-mineralization technology that distributes vital minerals in ionic forms to the teeth while supercharging natural tooth re-mineralization to keep teeth looking and feeling healthy. It was acquired by GSK- GlaxoSmithKline.
Do read about some of the most popular patents of NovaMin Technology which have been covered by us in this article and also you can find NovaMin Technology’s patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over NovaMin Technology’s patent portfolio.
How many patents does the Founder and CEO of NovaMin Technology have?
The Founder and CEO, Randy Scott has 0 patents.
How many patents does NovaMin Technology have?
NovaMin Technology has a total of 46 patents globally. These patents belong to 13 unique patent families. Out of 46 patents, 7 patents are active.
How many NovaMin Technology patents are Alive/Dead?
Worldwide Patents
Patent Families
How Many Patents did NovaMin Technology File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | NovaMin Technology Applications Filed | NovaMin Technology Patents Granted |
| 2011 | 2 | – |
| 2012 | 1 | 2 |
| 2013 | – | – |
| 2014 | – | 1 |
| 2015 | – | 3 |
| 2016 | – | – |
| 2017 | – | 1 |
How Many Patents did NovaMin Technology File in Different Countries?
Countries in which NovaMin Technology Filed Patents
| Country | Patents |
| United States Of America | 9 |
| Australia | 4 |
| Hong Kong (S.A.R.) | 4 |
| Japan | 4 |
| China | 3 |
| India | 3 |
| Mexico | 3 |
| Brazil | 2 |
| Canada | 2 |
| Europe | 2 |
| Russia | 2 |
| Poland | 1 |
| Korea (South) | 1 |
| Germany | 1 |
| South Africa | 1 |
| Taiwan | 1 |
Where are Research Centers of NovaMin Technology Patents Located?
10 Best NovaMin Technology Patents
US6338751B1 is the most popular patent in the NovaMin Technology portfolio. It has received 120 citations so far from companies like Pentron Clinical Technologies, Colgate-Palmolive and 3M Innovative.
Below is the list of 10 most cited patents of AmerisourceBergen:
| Publication Number | Citation Count |
| US6338751B1 | 120 |
| US6365132B1 | 96 |
| US6244871B1 | 90 |
| US6190643B1 | 62 |
| US6342207B1 | 46 |
| WO2009158564A1 | 45 |
| WO2005063185A1 | 44 |
| US20090324516A1 | 21 |
| WO2010041073A1 | 20 |
| US20070264291A1 | 18 |
What Percentage of NovaMin Technology US Patent Applications were Granted?
NovaMin Technology (Excluding its subsidiaries) has filed 15 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 8 have been granted leading to a grant rate of 61.54%.
Below are the key stats of NovaMin Technology patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for NovaMin Technology?
| Law Firm | Total Application | Success Rate |
| Glaxosmithkline | 10 | 70.00% |
| Buchanan Ingersoll & Rooney Pc | 2 | 0.00% |
| Bgl Research Triangle Park | 1 | 0.00% |
| James C Lydon | 1 | 100.00% |
| Ronald L Grudziecki | 1 | 0% |
List of NovaMin Technology Patents?
| NovaMin Technology Patents | Title |
| BRPI0914713A2 | COMPOSITION FOR ORAL CARE |
| CA2739941C | Tooth remineralisation film comprising a bioactive glass |
| AU2009300888B2 | Tooth remineralisation |
| JP5816549B2 | Compositions and methods for improving the fluoride uptake using bioactive glass |
| RU2549979C2 | Composition and method of increasing fluoride absorption with application of bioactive glass |
| EP2306961A4 | Composition and method for enhancing flouride uptake using bioactive glass |
| MX319905B | REMINERALIZATION OF TEETH. |
| JP5020833B2 | Bioactive glass composition |
| HK1159508A | Tooth remineralisation |
| ZA201009184B | Composition and method for enhancing flouride uptake using bioactive glass |
| JP2012505192A | Remineralization of teeth |
| US20110244430A1 | Tooth remineralisation |
| IN1509KOLNP2011A | Tooth remineralisation |
| CN102083404A | Composition and method for enhancing flouride uptake using bioactive glass |
| MX2010014243A | Composition and method for enhancing flouride uptake using bioactive glass. |
| IN4731KOLNP2010A | Composition and method for enhancing flouride uptake using bioactive glass |
| AU2009262061A1 | Composition and method for enhancing flouride uptake using bioactive glass |
| MX274470B | COMPOSITIONS AND METHODS FOR PREVENTING OR REDUCING THE PLATE AND / OR GINGIVITIS USING A DENTIFRICO CONTAINING BIOACTIVE GLASS. |
| WO2010041073A1 | Tooth remineralisation |
| US20100086497A1 | Tooth remineralisation |
| RU2378023C2 | Compositions and methods for prevention or reduction of dental deposit and/or gingivitis |
| US20090324516A1 | Composition and Method for Enhancing Flouride Uptake Using Bioactive Glass |
| WO2009158564A1 | Composition and method for enhancing flouride uptake using bioactive glass |
| EP1729722A4 | Compositions and methods for preventing or reducing plaque and/or gingivitis using a bioactive glass containing dentifrice |
| US20070264291A1 | Compositions and Methods for Preventing or Reducing Plaque and/or Gingivitis Using a Bioactive Glass Containing Dentefrice |
| IN3446DELNP2006A | “compositions and method for preventing or reducing pla que and/or gingivitis using a bioactive glass containing dentifrice” |
| HK1097739A | Compositions and methods for preventing or reducing plaque and/or gingivitis using a bioactive glass containing dentifrice |
| PL194695B1 | Method of and composition for whitening teeth |
| JP2007515427A | Compositions and methods for preventing plaque and / or gingivitis or reduced using bioactive glass-containing dentifrices |
| BRPI0417673A2 | METHODS FOR THE PREVENTION OR REDUCTION OF PLATE OR PLUMA PLATE AND GENGIVITE IN A INDIVIDUAL, NON-AQUEOUS COMPOSITION, AND TOOTHPASTE |
| CN1917852A | Compositions and methods for preventing or reducing plaque and/or gingivitis using a bioactive glass containing dentifrice |
| KR1020070015912A | Compositions and methods for preventing or reducing plaque and/or gingivitis using a bioactive glass containing dentifrice |
| AU2004308400A1 | Compositions and methods for preventing or reducing plaque and/or gingivitis using a bioactive glass containing dentifrice |
| HK1028959A1 | Methods and compositions for whitening teeth |
| CA2549787A1 | Compositions and methods for preventing or reducing plaque and/or gingivitis using a bioactive glass containing dentifrice |
| WO2005063185A1 | Compositions and methods for preventing or reducing plaque and/or gingivitis using a bioactive glass containing dentifrice |
| TWI228995B | A tooth-whitening oral hygiene composition |
| CN1149066C | Methods and compositions for whitening teeth |
| DE69530608T2 | Use of bioactive silica glass FOR MINERALIZATION OF DENTINE |
| HK1019222A1 | Bioactive glass compositions and methods of treatment using bioactive glass |
| US6365132B1 | Methods and compositions for whitening teeth |
| US6342207B1 | Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whitening and/or cleaning of an individual’s teeth |
| US6338751B1 | Compositions containing bioactive glass and their use in treating tooth hypersensitivity |
| AU741771B2 | Methods and compositions for whitening teeth |
| US6244871B1 | Bioactive glass compositions and methods of treatment using bioactive glass |
| US6190643B1 | Method for reducing the viability of detrimental oral microorganisms in an individual, and for prevention and/or treatment of diseases caused by such microorganisms; and whitening and/or cleaning of an individual’s teeth |